Medscape Diabetes & Endocrinology Podcast This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Basal Insulins: Affordable Alternatives
Drs Shubrook and Bertheau discuss alternatives to branded basal insulins and how to make the switch. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - April 3, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

Premixed Insulin: Best Practice Strategies
What are the pros and cons of using premixed insulin, both human and analog, in patients with type 2 diabetes? (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 27, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

Alt FOURIER: Diet and Exercise vs PCSK9i?
If Dr Walton-Shirley were designing the next trial on PCSK9 inhibitors, she ' d include a Mediterranean diet and exercise arm. She and Dr Mandrola ponder alternative uses of our healthcare dollars. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 24, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

FOURIER/EBBINGHAUS: So Far, So Good. But Can We Afford It?
Drs Harrington and Yancy review the efficacy and cognitive safety data for the PCSK9 inhibitor evolocumab, presented at the American College of Cardiology sessions. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 23, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

Kidney Patients Left in the Wind: A Heartfelt Story
Dr Szczech provides a sobering view on what extreme actions uninsured immigrants are taking to push their symptom boundaries to near death every week in order to get emergent hemodialysis. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 10, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

New Diabetes Drugs in Development
Dr John Buse highlights some of the new drugs and devices being developed for type 2 and type 1 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 10, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

Insulin: The Systemic Effects
We know that insulin can help patients with diabetes, but can it also place them in harm ' s way? (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - March 9, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

If Insulin Is Safe, Why Are Patients Afraid of It?
How can we address patients ' fears about insulin? Dr Shubrook speaks with Dr Jim LaSalle about the benefits of earlier use of insulin in patients with type 2 diabetes. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - February 23, 2017 Category: Endocrinology Authors: Medscape Source Type: podcasts

'Incredibly Exciting': Diabetes Drug With CV Benefits
The FDA ' s recent addition of a cardiovascular indication for diabetes drug empagliflozin is a significant milestone in diabetes care, says Dr Anne Peters. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - December 21, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts

Prediabetic Feet Deliver Profound Message
The healthy feet of patients with prediabetes represent a special opportunity for medical providers, says Dr Anne Peters. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - November 15, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts

EMPA-REG: Good News for Kidneys, Too
The positive effects of empagliflozin on renal disease are discussed by Dr Christoph Wanner, one of the lead authors of the EMPA-REG OUTCOME trial. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - November 1, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts

Less Hypoglycemia With Insulin Degludec?
Will ultra-long-acting insulin become the basal insulin of choice? Dr Carol Wysham discusses results of SWITCH 2 at EASD 2016. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - October 20, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts

EASD Brings Latest Diabetes Research to Clinical Practice
Applause again rang out over new drug data presented at EASD 2016, but meeting organizer Per-Henrik Groop says diabetes research was the real star of the conference. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - September 29, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts

Fighting Progression of Type 2 Diabetes
The key to slowing the progression of type 2 diabetes may be ' resting ' the pancreatic beta cells early in the disease rather than stimulating them to produce more insulin, says Dr Steven Kahn. (Source: Medscape Diabetes & Endocrinology Podcast)
Source: Medscape Diabetes & Endocrinology Podcast - September 23, 2016 Category: Endocrinology Authors: Medscape Source Type: podcasts